Current Programs - ExtendMed

A Firsthand Look at the ExtendMed Advantage

With a wide range of promotional and CME programs, ExtendMed has become a leading name in medical education. Here you can access a sampling of our recent programs. Please note that the programs marked CME are complete, fully-accredited courses available for medical certification.

(3 Hours)
SCOPE of Pain: Safe and Competent Opioid Prescribing Education

SCOPE of Pain: Safe and Competent Opioid Prescribing Education
17301 registrants. 10134 have completed the program.
SCOPE of pain is an educational program that will help you safely and competently manage your patients with chronic pain. Through the case of Mary Williams, a 42 year old with painful diabetic neuropathy and chronic low back pain, you'll learn how to: 1) decide on appropriateness of opioid analgesics; 2) assess for opioid misuse risk; 3) counsel patients about opioid safety, risks and benefits; 4) competently monitor patients prescribed opioids for benefit and harm; 5) make decisions on continuing or discontinuing opioid analgesics; 6) safely discontinue opioids when there is too little benefit or too much risk and harm. Offered in collaboration with the Council of Medical Specialty Societies (CMSS) and the Federation of State Medical Boards (FSMB), this program addresses the FDA mandate to manufacturers of extended release/long-acting (ER/LA) opioid analgesics, by providing comprehensive prescriber education in the safe use of these medications. It also addresses many key elements of the physician education component of the Obama Administration's prescription drug abuse prevention plan on prescriber education released in April 2011. This program is funded by an unrestricted educational grant awarded by the manufacturers of ER/LA opioid analgesics, known as the REMS Program Companies (RPC).

(60 minutes)
Clinical Updates in Anticoagulation Therapy for Stroke Prevention

Clinical Updates in Anticoagulation Therapy for Stroke Prevention
152 registrants. 41 have completed the program.
Through a free-form faculty discussion you will learn about the most up-to-date treatments in anticoagulation therapy for preventing stroke in patients with atrial fibrillation. Our expert faculty panel discusses a selection of the most important issues today including guidelines, bleeding risk, renal issues, the role of aspirin, current and new anticoagulants and perioperative management.This online continuing education program is brought to you by the Anticoagulation Forum and Boston University School of Medicine's Department of Continuing Medical Education.

(30 minutes)
Update on the Treatment Options for Opioid-Induced Constipation

Update on the Treatment Options for Opioid-Induced Constipation
59 registrants.
The majority of patients treated with opioid therapy for cancer and non-cancer pain experience opioid-induced constipation (OIC). OIC is a common and debilitating adverse event associated with chronic opioid therapy that is associated with a substantial clinical and economic burden. This condition is not trivial as it affects the patientâ??s quality of life and can lead them to reduce, discontinue or change effective analgesic therapy. While commonly used over-the-counter stool softeners and laxatives are generally effective; they do not address the underlying pathophysiological mechanism by which opioids cause OIC. Research advances have improved the understanding of those underlying mechanisms and have resulted in the identification of new pharmacologic agents that target the µ-opioid receptor interaction while maintaining the analgesic benefit of the opioid and minimizing the risk of withdrawal. This webcast is the second activity in a 3-module series that reviews current and evolving approaches to managing OIC.

SCOPE of Pain: Safe and Competent Opioid Prescribing Education: Kaiser Permanente Southern California

SCOPE of Pain: Safe and Competent Opioid Prescribing Education: Kaiser Permanente Southern California

SCOPE of pain is an educational program that will help you safely and competently manage your patients with chronic pain. Through the case of Mary Williams, a 42 year old with painful diabetic neuropathy and chronic low back pain, you'll learn how to: 1) decide on appropriateness of opioid analgesics; 2) assess for opioid misuse risk; 3) counsel patients about opioid safety, risks and benefits; 4) competently monitor patients prescribed opioids for benefit and harm; 5) make decisions on continuing or discontinuing opioid analgesics; 6) safely discontinue opioids when there is too little benefit or too much risk and harm. Offered in collaboration with the Council of Medical Specialty Societies (CMSS) and the Federation of State Medical Boards (FSMB), this program addresses the FDA mandate to manufacturers of extended release/long-acting (ER/LA) opioid analgesics, by providing comprehensive prescriber education in the safe use of these medications. It also addresses many key elements of the physician education component of the Obama Administration's prescription drug abuse prevention plan on prescriber education released in April 2011. This program is funded by an unrestricted educational grant awarded by the manufacturers of ER/LA opioid analgesics, known as the REMS Program Companies (RPC).